Advances and prospects of cell therapy for spinal cord injury patients

Huang, 2018, Review of clinical neurorestorative strategies for spinal cord injury: exploring history and latest progresses, J Neurorestoratol, 6, 171, 10.26599/JNR.2018.9040013 Lamond, 2015, Olfactory ensheathing cell in Neurorestoratology, Vol 1, 68 Huang, 2002, Preliminary report on clinical trial of olfactory ensheathing cell transplantation for spinal cord injury (in Chinese), J Navy General Hosp, 15, 18 Huang, 2003, Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury, Chin Med J (Engl), 116, 1488 Guest, 2006, Rapid recovery of segmental neurological function in a tetraplegic patient following transplantation of fetal olfactory bulb-derived cells, Spinal Cord, 44, 135, 10.1038/sj.sc.3101820 Huang, 2006, Influence factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury (in Chinese), Chin J Reparative Reconstr Surg, 20, 434 Huang, 2006, Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury. A 38-month follow-up with MRI (in Chinese), Chin J Reparative Reconstr Surg, 20, 439 Huang, 2009, Olfactory ensheathing cells transplantation for central nervous system diseases in 1, 255 patients (in Chinese), Chin J Reparative Reconstr Surg, 23, 14 Huang, 2012, Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury, Cell Transplant, 21, S23, 10.3727/096368912X633734 Chen, 2014, A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries, Cell Transplant, 23, S35, 10.3727/096368914X685014 Rabinovich, 2003, Transplantation treatment of spinal cord injury patients, Biomed Pharmacother, 57, 428, 10.1016/j.biopha.2003.05.001 Seledtsova, 2010, Delayed results of transplantation of fetal neurogenic tissue in patients with consequences of spinal cord trauma, Bull Exp Biol Med, 149, 530, 10.1007/s10517-010-0985-1 Féron, 2005, Autologous olfactory ensheathing cell transplantation in human spinal cord injury, Brain, 128, 2951, 10.1093/brain/awh657 Mackay-Sim, 2008, Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial, Brain, 131, 2376, 10.1093/brain/awn173 Chen, 2018, Comparison of intramedullary transplantation of olfactory ensheathing cell for patients with chronic complete spinal cord injury worldwide, J Neurorestoratol, 6, 146, 10.26599/JNR.2018.9040012 Wu, 2012, Clinical observation of fetal olfactory ensheathing Glia transplantation (OEGT) in patients with complete chronic spinal cord injury, Cell Transplant, 21, S33, 10.3727/096368912X633743 Zheng, 2007, Olfactory ensheathing cell transplantation in 106 patients with old spinal cord injury: differences in ages, sexes, disease courses, injured types and sites, Neural Regen Res, 2, 380, 10.1016/S1673-5374(07)60071-1 Zheng, 2013, Olfactory ensheathing cell transplantation improves sympathetic skin responses in chronic spinal cord injury, Neural Regen Res, 8, 2849 Kuang, 2021, Olfactory ensheathing cell transplantation for chronic spinal cord injury: a long-term follow-up study, J Neurorestoratol, 9, 94, 10.26599/JNR.2021.9040008 Bao, 2007, Olfactory ensheathing cell transplantation in the treatment of spinal cord injury in 5 cases (in Chinese), J Clin Rehabilitative Tissue Eng Res, 11, 512 Rao, 2013, Clinical application of olfactory ensheathing cells in the treatment of spinal cord injury, J Int Med Res, 41, 473, 10.1177/0300060513476426 Rao, 2013, Long-term outcome of olfactory ensheathing cell transplantation in six patients with chronic complete spinal cord injury, Cell Transplant, 22, 21, 10.3727/096368913X672127 Rao, 2014, Effectiveness of olfactory ensheathing cell transplantation for treatment of spinal cord injury, Genet Mol Res, 13, 4124, 10.4238/2014.May.30.7 Tabakow, 2013, Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury, Cell Transplant, 22, 1591, 10.3727/096368912X663532 Tabakow, 2014, Functional regeneration of supraspinal connections in a patient with transected spinal cord following transplantation of bulbar olfactory ensheathing cells with peripheral nerve bridging, Cell Transplant, 23, 1631, 10.3727/096368914X685131 Cheng, 2021, Ten years of clinical observation of olfactory ensheathing cell transplantation in patients with spinal cord injury, J Neurorestoratol, 9, 106, 10.26599/JNR.2021.9040009 Zamani, 2022, Safety and feasibility of autologous olfactory ensheathing cell and bone marrow mesenchymal stem cell co-transplantation in chronic human spinal cord injury: a clinical trial, Spinal Cord, 60, 63, 10.1038/s41393-021-00687-5 Lima, 2006, Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study, J Spinal Cord Med, 29, 191, 10.1080/10790268.2006.11753874 Lima, 2010, Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury, Neurorehabil Neural Repair, 24, 10, 10.1177/1545968309347685 Chhabra, 2009, Autologous olfactory[corrected]mucosal transplant in chronic spinal cord injury: an Indian Pilot Study, Spinal Cord, 47, 887, 10.1038/sc.2009.54 Iwatsuki, 2016, A pilot clinical study of olfactory mucosa autograft for chronic complete spinal cord injury, Neurol Med Chir (Tokyo), 56, 285, 10.2176/nmc.oa.2015-0320 Wang, 2016, Autologous olfactory Lamina propria transplantation for chronic spinal cord injury: three-year follow-up outcomes from a prospective double-blinded clinical trial, Cell Transplant, 25, 141, 10.3727/096368915X688065 Dlouhy, 2014, Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: case report, J Neurosurg Spine, 21, 618, 10.3171/2014.5.SPINE13992 Williamson, 2020, Autograft- derived spinal cord mass in the cervical spine following transplantation with olfactory mucosa cells for traumatic spinal cord injury: case report, J Neurosurg Spine, 1 Park, 2005, Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor, Tissue Eng, 11, 913, 10.1089/ten.2005.11.913 Syková, 2006, Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury, Cell Transplant, 15, 675, 10.3727/000000006783464381 Yoon, 2007, Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial, Stem Cells, 25, 2066, 10.1634/stemcells.2006-0807 Chernykh, 2007, Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients, Bull Exp Biol Med, 143, 543, 10.1007/s10517-007-0175-y Cristante, 2009, Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients, Spinal Cord, 47, 733, 10.1038/sc.2009.24 Kumar, 2009, Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: a phase I/II clinical safety and primary efficacy data, Exp Clin Transplant, 7, 241 El-Kheir, 2014, Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients, Cell Transplant, 23, 729, 10.3727/096368913X664540 Sharma, 2014, Functional recovery in chronic stage of spinal cord injury by neurorestorative approach: a case report, Case Rep Surg, 2014 Hemangi Sane, 2013, Role of autologous bone marrow mononuclear cells in chronic cervical spinal cord injury-A longterm follow up study, J Neurol Disord, 1, 138, 10.4172/2329-6895.1000138 Sharma, 2013, Detailed analysis of the clinical effects of cell therapy for thoracolumbar spinal cord injury: an original study, J Neurorestoratol, 13, 10.2147/JN.S43712 Sharma, 2020, Intrathecal transplantation of autologous bone marrow mononuclear cells in patients with sub-acute and chronic spinal cord injury: an open-label study, Int J Health Sci (Qassim), 14, 24 Zhu, 2016, Phase I-II clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury, Cell Transplant, 25, 1925, 10.3727/096368916X691411 Kakabadze, 2016, Phase 1 trial of autologous bone marrow stem cell transplantation in patients with spinal cord injury, Stem Cells Int, 2016, 10.1155/2016/6768274 Liem, 2018, Improved bowel function in patients with spina bifida after bone marrow-derived mononuclear cell transplantation: a report of 2 cases, Am J Case Rep, 19, 1010, 10.12659/AJCR.909801 Srivastava, 2019, Effectiveness of bone marrow-derived mononuclear stem cells for neurological recovery in participants with spinal cord injury: a randomized controlled trial, Asian J Transfus Sci, 13, 120, 10.4103/ajts.AJTS_44_18 Xiao, 2016, One-year clinical study of NeuroRegen scaffold implantation following scar resection in complete chronic spinal cord injury patients, Sci China Life Sci, 59, 647, 10.1007/s11427-016-5080-z Chen, 2020, NeuroRegen scaffolds combined with autologous bone marrow mononuclear cells for the repair of acute complete spinal cord injury: a 3-year clinical study, Cell Transplant, 29, 10.1177/0963689720950637 Derakhshanrad, 2018, Subcutaneous granulocyte colony-stimulating factor administration for subacute traumatic spinal cord injuries, report of neurological and functional outcomes: a double-blind randomized controlled clinical trial, J Neurosurg Spine, 30, 19, 10.3171/2018.6.SPINE18209 Derakhshanrad, 2018, Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial, J Neurosurg Spine, 29, 97, 10.3171/2017.11.SPINE17769 Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905 Galipeau, 2016, International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials, Cytotherapy, 18, 151, 10.1016/j.jcyt.2015.11.008 Kang, 2005, A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study, Cytotherapy, 7, 368, 10.1080/14653240500238160 Geffner, 2008, Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies, Cell Transplant, 17, 1277, 10.3727/096368908787648074 Pal, 2009, Ex vivo- expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study, Cytotherapy, 11, 897, 10.3109/14653240903253857 Kishk, 2010, Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury, Neurorehabil Neural Repair, 24, 702, 10.1177/1545968310369801 Park, 2012, Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans, Neurosurgery, 70, 1238, 10.1227/NEU.0b013e31824387f9 Oh, 2016, A phase III clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury, Neurosurgery, 78, 436, 10.1227/NEU.0000000000001056 Liu, 2013, Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells, Cytotherapy, 15, 185, 10.1016/j.jcyt.2012.09.005 Dai, 2013, Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury, Brain Res, 1533, 73, 10.1016/j.brainres.2013.08.016 Yazdani, 2013, Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury, Cytotherapy, 15, 782, 10.1016/j.jcyt.2013.03.012 Oraee-Yazdani, 2016, Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome, Spinal Cord, 54, 102, 10.1038/sc.2015.142 Oraee-Yazdani, 2021, Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes, Stem Cell Res Ther, 12, 445, 10.1186/s13287-021-02515-2 Mendonça, 2014, Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury, Stem Cell Res Ther, 5, 126, 10.1186/scrt516 Chotivichit, 2015, Chronic spinal cord injury treated with transplanted autologous bone marrow-derived mesenchymal stem cells tracked by magnetic resonance imaging: a case report, J Med Case Rep, 9, 79, 10.1186/s13256-015-0535-6 Satti, 2016, Autologous mesenchymal stromal cell transplantation for spinal cord injury: a Phase I pilot study, Cytotherapy, 18, 518, 10.1016/j.jcyt.2016.01.004 Vaquero, 2016, An approach to personalized cell therapy in chronic complete paraplegia: the Puerta de Hierro phase I/II clinical trial, Cytotherapy, 18, 1025, 10.1016/j.jcyt.2016.05.003 Vaquero, 2017, Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury, Cytotherapy, 19, 349, 10.1016/j.jcyt.2016.12.002 Vaquero, 2018, Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: safety and efficacy of the 100/3 guideline, Cytotherapy, 20, 806, 10.1016/j.jcyt.2018.03.032 Vaquero, 2018, Intrathecal administration of autologous bone marrow stromal cells improves neuropathic pain in patients with spinal cord injury, Neurosci Lett, 670, 14, 10.1016/j.neulet.2018.01.035 Vaquero, 2018, Cell therapy with autologous mesenchymal stromal cells in post- traumatic syringomyelia, Cytotherapy, 20, 796, 10.1016/j.jcyt.2018.04.006 Larocca, 2017, Image- guided percutaneous intralesional administration of mesenchymal stromal cells in subjects with chronic complete spinal cord injury: a pilot study, Cytotherapy, 19, 1189, 10.1016/j.jcyt.2017.06.006 Guadalajara Labajo, 2018, Objective demonstration of improvement of neurogenic bowel dysfunction in a case of spinal cord injury following stem cell therapy, J Surg Case Rep, 2018, 10.1093/jscr/rjy300 Santamaría, 2019, Clinical and neurophysiological changes after targeted intrathecal injections of bone marrow stem cells in a C3 tetraplegic subject, J Neurotrauma, 36, 500, 10.1089/neu.2018.5716 Phedy, 2019, Motoric recovery after transplantation of bone marrow derived mesenchymal stem cells in chronic spinal cord injury: a case report, Am J Case Rep, 20, 1299, 10.12659/AJCR.917624 Bydon, 2020, CELLTOP clinical trial: first report from a phase 1 trial of autologous adipose tissue-derived mesenchymal stem cells in the treatment of paralysis due to traumatic spinal cord injury, Mayo Clin Proc, 95, 406, 10.1016/j.mayocp.2019.10.008 Yang, 2021, Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study, Cytotherapy, 23, 57, 10.1016/j.jcyt.2020.09.012 Albu, 2021, Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study, Cytotherapy, 23, 146, 10.1016/j.jcyt.2020.08.008 Bryukhovetskiy, 2015, Tissue Engineering of spinal cord injury in Neurorestoratology, Vol 2, 45 Zhao, 2017, Clinical study of NeuroRegen scaffold combined with human mesenchymal stem cells for the repair of chronic complete spinal cord injury, Cell Transplant, 26, 891, 10.3727/096368917X695038 Xiao, 2018, Significant improvement of acute complete spinal cord injury patients diagnosed by a combined criteria implanted with NeuroRegen scaffolds and mesenchymal stem cells, Cell Transplant, 27, 907, 10.1177/0963689718766279 Tang, 2021, Long-term clinical observation of patients with acute and chronic complete spinal cord injury after transplantation of NeuroRegen scaffold, Sci China Life Sci Saberi, 2008, Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes, Neurosci Lett, 443, 46, 10.1016/j.neulet.2008.07.041 Saberi, 2011, Safety of intramedullary Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases, J Neurosurg Spine, 15, 515, 10.3171/2011.6.SPINE10917 Zhou, 2012, Transplantation of autologous activated Schwann cells in the treatment of spinal cord injury: six cases, more than five years of follow-up, Cell Transplant, 21, S39, 10.3727/096368912X633752 Anderson, 2017, Safety of autologous human schwann cell transplantation in subacute thoracic spinal cord injury, J Neurotrauma, 34, 2950, 10.1089/neu.2016.4895 Santamaria, 2020, Neurophysiological changes in the first year after cell transplantation in sub-acute complete paraplegia, Front Neurol, 11 Gant, 2022, Phase 1 safety trial of autologous human Schwann cell transplantation in chronic spinal cord injury, J Neurotrauma, 39, 285, 10.1089/neu.2020.7590 Deda, 2008, Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up, Cytotherapy, 10, 565, 10.1080/14653240802241797 Al-Zoubi, 2014, Transplantation of purified autologous leukapheresis-derived CD34+ and CD133+ stem cells for patients with chronic spinal cord injuries: long-term evaluation of safety and efficacy, Cell Transplant, 23, S25, 10.3727/096368914X684899 Ammar, 2017, A method for reconstruction of severely damaged spinal cord using autologous hematopoietic stem cells and platelet- rich protein as a biological scaffold, Asian J Neurosurg, 12, 681, 10.4103/ajns.AJNS_351_16 Scott, 2014, Wrongful termination: lessons from the Geron clinical trial, Stem Cells Transl Med, 3, 1398, 10.5966/sctm.2014-0147 Thakkar, 2016, Infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and hematopoietic stem cells in post-traumatic paraplegia offers a viable therapeutic approach, Adv Biomed Res, 5, 51, 10.4103/2277-9175.178792 Shin, 2015, Clinical trial of human fetal brain-derived neural stem/progenitor cell transplantation in patients with traumatic cervical spinal cord injury, Neural Plast, 2015, 10.1155/2015/630932 Curtis, 2018, A first-in-human, phase I study of neural stem cell transplantation for chronic spinal cord injury, Cell Stem Cell, 22, 941, 10.1016/j.stem.2018.05.014 Levi, 2018, Emerging safety of intramedullary transplantation of human neural stem cells in chronic cervical and thoracic spinal cord injury, Neurosurgery, 82, 562, 10.1093/neuros/nyx250 Levi, 2019, Clinical outcomes from a multi-center study of human neural stem cell transplantation in chronic cervical spinal cord injury, J Neurotrauma, 36, 891, 10.1089/neu.2018.5843 Curt, 2020, The damaged spinal cord is a suitable target for stem cell transplantation, Neurorehabil Neural Repair, 34, 758, 10.1177/1545968320935815 Sugai, 2021, First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: study protocol, Regen Ther, 18, 321, 10.1016/j.reth.2021.08.005 Moviglia, 2006, Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients, Cytotherapy, 8, 202, 10.1080/14653240600736048 Moviglia, 2009, Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients, Spinal Cord, 47, 499, 10.1038/sc.2008.164 Moviglia, 2018, Local immunomodulation and muscle progenitor cells induce recovery in atrophied muscles in spinal cord injury patients, J Neurorestoratol, 6, 136, 10.26599/JNR.2018.9040011 Xiang, 2020, Standards of clinical-grade mesenchymal stromal cell preparation and quality control (2020 China Version), J Neurorestoratol, 8, 197, 10.26599/JNR.2020.9040021 Huang, 2020, Standards of clinical-grade olfactory ensheathing cell culture and quality control (2020 China Version), J Neurorestoratol, 8, 217, 10.26599/JNR.2020.9040023 Huang, 2018, Clinical cell therapy guidelines for neurorestoration (IANR/CANR 2017), Cell Transplant, 27, 310, 10.1177/0963689717746999 Huang, 2019, Clinical neurorestorative therapeutic guidelines for spinal cord injury (IANR/CANR version 2019), J Orthop Translat, 20, 14, 10.1016/j.jot.2019.10.006 Guo, 2021, Clinical guidelines for neurorestorative therapies in spinal cord injury (2021 China version), J Neurorestoratol, 9, 31, 10.26599/JNR.2021.9040003